Australia develops artificial skin for the treatment of skin ulcers

Release date: 2006-10-17

A breakthrough in wound care has been made by Australian scientist Chris Jackson, who recently developed an innovative artificial skin designed to treat skin ulcers. In clinical trials, patients who used the artificial skin for four weeks experienced a reduction of up to 20% in ulcer size. Beyond just shrinking the affected area, the artificial skin also helps reduce inflammation, redness, and the risk of infection, promoting faster healing. Dr. Kelly, a dermatologist involved in the study, noted that all patients showed improvement, with some experiencing a significant reduction in wound size after just four treatments. The initial phase of the experiment has been successful, and the next step is to test the product on a broader population. Skin ulcers are deep wounds that occur below the dermis or within the skin layer. They often appear with pus, dead tissue, or scabs, and can leave scars. These wounds may result from infections, injuries, or the rupture of nodules or tumors. Their appearance, depth, and progression can vary widely. Many patients with chronic wounds are elderly, and these ulcers commonly develop in areas with poor blood circulation, such as the legs and feet. This new treatment offers hope for those suffering from long-term skin damage and could significantly improve quality of life. "Meddy Medical Network"

Finished Dosage Formulation

herpes zoster vaccine,Hepatitis B Vaccine For Adults,Tetanus Booster

FOSHAN PHARMA CO., LTD. , https://www.forepharm.com

Posted on